Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis-C-Infected Persons: An Online Survey.

HCV counseling recommendations hepatitis C

Journal

Infectious diseases in clinical practice (Baltimore, Md.)
ISSN: 1056-9103
Titre abrégé: Infect Dis Clin Pract (Baltim Md)
Pays: United States
ID NLM: 9204234

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 28 8 2021
Statut: ppublish

Résumé

Current hepatitis C virus (HCV) counseling guidelines do not recommend that HCV-infected patients notify their partners or encourage them to get tested. We aimed to assess healthcare professionals' knowledge of and attitudes toward counseling and testing recommendations for HCV-infected patients. A 15-question, anonymous survey was designed and distributed via email to a convenience sample of healthcare professionals who work with Brown University or Boston University affiliated hospitals to assess their knowledge of and attitudes toward counseling recommendations for HCV-infected patients. The data was collected electronically and analyzed using descriptive statistical methods. Of the 55 respondents (a 20% response rate), 73% incorrectly believed that, at the time the survey was completed, CDC HCV testing guidelines already recommended partners of HCV-infected patients be tested for HCV infection. Furthermore, 80% of respondents believed recommendations should be revisited to explicitly include that HCV-infected patients encourage their partners to get tested. When counseling patients with HCV, 44% of respondents reported they always ask whether the patient's partners have been tested for HCV and 42% reported they sometimes do. Similarly, 42% reported they always suggest that the HCV-infected patient's partners be tested for HCV. Our survey shows that healthcare providers believe that HCV-counseling and testing recommendations could be revisited, with specific attention given to the promotion of HCV testing for partners of HCV-infected patients.

Sections du résumé

BACKGROUND BACKGROUND
Current hepatitis C virus (HCV) counseling guidelines do not recommend that HCV-infected patients notify their partners or encourage them to get tested. We aimed to assess healthcare professionals' knowledge of and attitudes toward counseling and testing recommendations for HCV-infected patients.
METHODS METHODS
A 15-question, anonymous survey was designed and distributed via email to a convenience sample of healthcare professionals who work with Brown University or Boston University affiliated hospitals to assess their knowledge of and attitudes toward counseling recommendations for HCV-infected patients. The data was collected electronically and analyzed using descriptive statistical methods.
RESULTS RESULTS
Of the 55 respondents (a 20% response rate), 73% incorrectly believed that, at the time the survey was completed, CDC HCV testing guidelines already recommended partners of HCV-infected patients be tested for HCV infection. Furthermore, 80% of respondents believed recommendations should be revisited to explicitly include that HCV-infected patients encourage their partners to get tested. When counseling patients with HCV, 44% of respondents reported they always ask whether the patient's partners have been tested for HCV and 42% reported they sometimes do. Similarly, 42% reported they always suggest that the HCV-infected patient's partners be tested for HCV.
CONCLUSIONS CONCLUSIONS
Our survey shows that healthcare providers believe that HCV-counseling and testing recommendations could be revisited, with specific attention given to the promotion of HCV testing for partners of HCV-infected patients.

Identifiants

pubmed: 34447237
doi: 10.1097/ipc.0000000000000950
pmc: PMC8384264
mid: NIHMS1707400
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e151-e153

Subventions

Organisme : NIAID NIH HHS
ID : R25 AI140490
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors declare no conflicts of interest.

Références

PLoS One. 2012;7(10):e47335
pubmed: 23110068
Hepatology. 2013 Mar;57(3):881-9
pubmed: 23175457
Hepatology. 2014 Dec;60(6):1861-70
pubmed: 25163856
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17
pubmed: 32271723

Auteurs

Katherine Dunham (K)

Division of General Internal Medicine, Mount Sinai Health System, New York, NY.
Brown University, Providence, RI.

Jessica McDonald (J)

Brown University, Providence, RI.

Anna Yousaf (A)

Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI.
The Miriam Hospital, Providence, RI, USA.

Joshua A Barocas (JA)

Division of Infectious Diseases, Boston Medical Center, Boston, MA.
Boston University School of Medicine, Boston, MA.

Marguerite Neill (M)

Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI.
The Miriam Hospital, Providence, RI, USA.

Amanda Noska (A)

Essentia Hospital/St. Mary's Medical Center, Duluth, MN, USA.

Timothy P Flanigan (TP)

Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI.
The Miriam Hospital, Providence, RI, USA.

Classifications MeSH